
Proceedings of the WFH’s Ninth WFH Global Forum on Research and Treatment Products for Bleeding Disorders
A summary of discussions held at the Ninth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Document
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

A summary of discussions held at the Ninth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

Quality data are extremely useful in advocating for better care for people with bleeding disorders. This Fact Sheet introduces the

This guide explains how a national procurement system of factor concentrates can help to ensure that people with bleeding disorders

A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia

A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders

A discussion of the mild forms of hemophilia A and hemophilia B, from epidemiology and molecular basis, via diagnosis, to